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Abstract
S-Nitroso(sy)lation reactions have recently been appreciated to regulate protein function and mediate ‘nitrosative’ stress.
S-Nitrosothiols (SNOs) have been identified in a variety of tissues, and represent a novel class of signaling molecules which
may act independently of homolytic cleavage to NO ^ and, indeed, in a stereoselective fashion ^ or be metabolized to other
bioactive nitrogen oxides. It is now appreciated that sulfur^NO interactions have critical physiological relevance to
mammalian neurotransmission, ion channel function, intracellular signaling and antimicrobial defense. These reactions are
promising targets for the development of new medical therapies. ß 1999 Elsevier Science B.V. All rights reserved.
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1. Introduction
Ignarro et al. demonstrated that reactions with
cellular thiols contributed to the bioactivities of cer-
tain pharmacological nitrogen oxide (NOx) donors in
1981 [1], several years before making the observation
that nitric oxide (NO) is synthesized endogenously in
mammalian cells [2]. Kowaluk and Fung later
showed that S-nitrosothiols (SNOs) ^ thiol^NO ad-
ducts ^ exerted bioactivities independent of break-
down to NO [3]. However, there was little general
interest in thiol^NO interactions until Stamler and
coworkers focused attention on SNOs as nitroso-
nium (NO) and nitroxyl (NO3) donors with chem-
ical reactivities distinct from those of NO [4] (Fig. 1)
which were: (1) capable of forming in ^ and modify-
ing ^ proteins; and (2) present in mammalian tissue
[5,6]. It is now evident that thiol^NO chemistry is
relevant to immune, antimicrobial, smooth muscle
relaxant and neuronal bioactivities, and that NOx,
like Marines carried in an amphibious task force,
may be protected from harm, transported to the
point of attack, and act with enhanced e¡ectiveness
following reaction with carrier thiol groups. Here, we
will review: (1) nitrosative chemistry as it applies to
sulfhydryl groups in biological systems; (2) current
measurement techniques for SNOs; (3) the location
and composition of known SNO reservoirs in mam-
malian species; (4) SNO metabolism, speci¢cally in-
cluding both formation and catabolic fate; and (5)
recent insights regarding the mechanisms by which
thiol^NO interactions may exert bioactivities.
2. Nitrosative chemistry and the chemistry of related
NO groups
The reactivity of NO with sulfhydryl (R^SH)
groups depends on the electron con¢guration of its
2p-2 antibonding orbital, as recently reviewed [4].
The presence of one (radical) electron in this orbital
does not ordinarily confer reactivity with R^SH
groups (Fig. 1), though it clearly allows reaction
with thiyl radical species. On the other hand, loss
of this electron to form NO confers strong electro-
philicity and reactivity towards most biological R^
SH species [4,7]. A second electron in the 2p-H orbi-
tal, forming NO3, may under certain circumstances
confer reactivity with relatively electropositive R^SH
species, particularly in the presence of ferrous ion or
other transition metals [4,7,8]. Of note, nitric oxide
synthase (NOS) may produce nitrous oxide (N2O)
and hydroxylamine (NH2OH) from NO3 [9]. Fur-
ther, coproduction of NO and superoxide may
form peroxynitrite (ONOO3). This is a potent nitro-
sating species, especially in the presence of excess
NO.
The third-order reactivity of NO with oxygen
under physiological conditions (rate constant in
aqueous phase V6.6U106 M32 s31) [10] predicts rel-
atively slow production of dinitrogen trioxide (N2O3)
as a nitrosating agent as (NO:..NO32 ). Of note, the
reaction is accelerated 300-fold in the hydrophilic
core of biological membranes [11]. Reactions of
NO with superoxide, on the other hand, are so rapid
as to be di¡usion limited (k =V7U109 M31 s31)
[12]. Both amines and sulfhydryl groups are highly
Fig. 1. Interconversion of the redox-related forms of NO. Three
pathways of potential biological signi¢cance are shown, involv-
ing metal (M) nitrosyl complexes, charge transfer to electron
acceptors (A), and coupling to thiol/disul¢de redox reactions.
Reproduced with permission from [4].
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susceptible to reactions with N2O3 and ONOO3
[9,11,13,14]. Thiol nitros(yl)ation is preferred under
physiological conditions, both because of the ten-
dency of amines to be more basic and because, unlike
deamination of primary amines after NO-induced
diazotization [4,13], loss of the SNO group thiolate
does not generally occur rapidly. Reactivity of these
nitrosating species toward carbon groups is less than
toward amino groups and sulfhydryl groups. It is
therefore not surprising that S-nitrosylation of pro-
teins has been demonstrated to be preferred over N-
and C-nitrosation under physiological conditions [15]
and that large, stable reservoirs of SNO, but not N^
NO or C^NO, species have been identi¢ed in tissues
[5,6,16^18].
3. S-Nitrosothiol measurement
Several techniques are now available for SNO as-
say. Traditional spectrophotometric assays, which
are sensitive to approximately 500 nM, include
both: (1) measurement of the characteristic absorb-
ance of the S^NO bond at 340 nm [5,6]; and (2)
heterolytic cleavage of the bond using excess mercu-
ric chloride (HgCl2) with subsequent assay for nitrite
(NO32 ) formed from NO
 in water [5,6,19]. Forma-
tion of diamino naphthalene with assay by £uores-
cence is more sensitive than colorimetric assays, but
both reactions may be inhibited in the presence of
proteins [18]. The lower limit of sensitivity of S^NO
assays may be improved upon, and S-nitrosoproteins
more reliably assayed, using reactions which cause
homolytic cleavage of the S^NO bond and subse-
quent assay for NO by chemiluminescence. Classi-
cally, this cleavage is carried out by photolysis
[5,6], though these assays may be expensive and cum-
C
Fig. 2. S-Nitrosoglutathione: detection in tracheal aspirates. In
the presence of cuprous ion, CSNO, but not GSNO, decom-
poses rapidly to NO. The transnitrosation reactions which con-
vert GSNO and other SNOs to CSNO in the presence of excess
cysteine may therefore be exploited, in the presence of CuCl, to
measure SNOs as NO. (a) GSNO (100 WM), in phosphate-buf-
fered saline (PBS), slowly liberates NO as measured by chemilu-
minescence in a helium (He) stream (open arrow). Addition of
excess cysteine (1 mM) and CuCl (100 WM) (closed arrow) re-
sults in liberation of all SNO-bound NO (presented in mV as
the raw signal from the photoelectric response). Assays that fol-
low represent addition of SNO to 1 mM cysteine and 100 WM
CuCl (50‡C in He) (CSNO/Cu) as described. S-Nitrosohomo-
systeine (HCSNO), CSNO and GSNO assays were linear to
5 nM, were strongly correlated with standard spectrophoto-
metric assays [1,13] in the range of spectrophotometric sensitiv-
ity (s 1 WM; r2s 0.9) and were highly speci¢c, failing to detect
ten WM NO33 , NO
3
2 and 3-nitrotyrosine. (b) S-Nitrosothiols
were assayed at 1-min intervals after C-18 reverse phase HPLC
separation (mobile phase 20% methanol, 80% sodium phosphate
bu¡er, 1 mM 1-octanesulfonic acid by CSNO/Cu. These obser-
vations con¢rm that: (1) SNOs may be distinguished by HPLC
followed by copper reduction as reported [20] ; (2) GSNO is the
principal SNO in human ALF; and (3) this GSNO peak is
missing in asthmatic ALF.
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bersome. More recently, reaction with excess (1 mM)
cysteine and cuprous chloride (100 WM) (CuCl/cys-
teine) has been shown to provide a linear assay for
SNOs to 5 nM [20] (Fig. 2). With both homolytic
cleavage-based assays, it is important to demonstrate
that NO signal is lost by pre-incubation with excess
HgCl2 [5,6] because each can detect contaminating
nitrite (NO32 ). Of note, NO
3
2 detection using the
CuCl/cysteine method is eliminated if the reaction
is carried out at pH 6^8 (unpublished observations).
Cupric chloride has been used to assay SNOs by
heterolytic cleavage, with subsequent colorimetric
NO32 assay [21]. This assay is sensitive, but is largely
unproven with regard to biological samples. Each of
these general classes of assays may be coupled with
high pressure liquid phase chromatography (HPLC)
for separating SNO species. Several di¡erent HPLC
systems have been developed for this purpose [21^25]
(Fig. 2). Theoretical concerns exist regarding artifac-
tual formation of SNOs in the presence of NO32 at
low pH in mobile phase, which may require pre-
treatment of the sample with ammonium sulfamate
[6,17], and these systems have not been formally
compared with one another. Finally, SNOs may be
de¢nitively identi¢ed by mass spectrometry and char-
acterized in biochemical pathways using 15N labeling
[15,17].
4. S-Nitrosothiol reservoirs
Unlike NO, tissue concentrations of which may be
limited to the low nM range by considerations of
di¡usion and reactivity [26], SNO concentrations in
general, and S-nitrosoglutathione (GSNO) concen-
trations in particular, may be in the WM range
[6,17]. Endogenous GSNO was ¢rst described in hu-
man airways, and airway levels are now known to be
elevated in patients with pneumonia and to be de-
pleted in patients with asthma [6,20]. S-Nitrosoglu-
tathione and other SNOs have also been identi¢ed in
erythrocytes, polymorphonuclear leukocytes, brain
tissue, platelets and plasma [16,18,20,27^30]. Of
note, intracellular SNOs may be responsible for the
nitrinergic photorelaxation response of smooth
muscle cells originally described in 1989 [31]. S-Ni-
trosoglutathione may be favored over other SNOs in
these reservoirs, except in plasma and erythrocytes,
because of: (1) its stability (relative, for example, to
S-nitrosocysteine (CSNO) [5,32]); (2) favorable ki-
netics and thermodynamics for its formation in
transnitrosation reactions from other endogenous
low mass (LM) SNOs [33,34]; and (3) the high en-
dogenous substrate reduced glutathione (GSH) con-
centrations in many tissues [30,35]. However, CSNO,
S-nitrosocysteinyl glycine and S-nitrosated proteins
have been identi¢ed in plasma and cell systems,
and high nM concentrations of S-nitrosohemoglobin
are present in oxygenated erythrocytes [16]. The role
of these pools of GSNO and other SNOs would ap-
pear to be cell- and tissue-speci¢c and to be regu-
lated, at least in part, by speci¢c metabolic pathways.
5. Sulfur nitros(yl)ation in biological systems
Electrophilic reactions of NO with cysteinyl sulf-
hydryl moieties is now appreciated to be responsible
for a wide range of protein modi¢cations. These may
be thought of as being analogous to serine, threo-
nine, and tyrosine phosphorylation. While reactions
of nitronium (NO2 ) may result in tyrosine nitration
under physiological conditions, particularly in the
presence of carbon dioxide [12,36,37], reactions of
NO equivalents with sulfhydryl groups are favored
over those with nitrogen and carbon in most circum-
stances. In this regard, it should be observed that
tyrosine nitration reactions may not be regulatory,
while cysteine nitrosylation reactions are. As noted
above, these nitrosating reactivities may be conferred
upon NO by inorganic reactions with oxygen species.
Additionally, SNO formation is facilitated through
electron transfer in iron nitrosyl groups (Fe (S)
NO) in vitro [8], and this process may be relevant
in vivo as well.
Importantly, hemoglobin may serve as a catalyst
for SNO formation under conditions of high oxygen
a⁄nity, in which S-nitrosylation of the single L-chain
reduced cysteine (93) is favored [16,38]. The resulting
SNO^hemoglobin synthesis in the lung allows for
LM SNO formation through transnitrosation reac-
tions [16] (Fig. 3). The circulatory system may thus
provides end organs with a steady supply of LM
SNOs which can di¡use out of the erythrocyte and
into tissues [16]. Furthermore, NOS activation itself
may form SNOs, perhaps through intermediate
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ONOO3 in the presence of thiol [9,14]. Additional
SNO synthetic reactions may occur in vivo, such as
protein nitrosylation by nitrous acid (HNO2) in
acidic organelles, but these remain to be clari¢ed.
6. S-Nitrosothiol breakdown in biological systems
In many tissues, SNO concentrations, sites of ac-
tion and bioactivities may be regulated more by ca-
tabolic processes than by synthesis. In this regard,
several enzymes have been described to break down
LM SNO in vitro [39^44] (Table 1). The relative
distribution of these enzymes in di¡erent tissues
could dramatically alter S^NO bioactivities. In the
lung, for example, Q-glutamyl transpeptidase, which
converts GSNO to S-nitrosocysteinyl glycine [25],
may confer greater membrane permeability for sub-
mucosal/smooth muscle bioactivity, while xanthine
oxidase, in the presence of xanthine, has the potential
to catalyze CSNO breakdown to cytotoxic ONOO3
[39]. Furthermore, glutathione peroxidase (GSPX)
theoretically may produce NO [40,41] with the net
e¡ect of inactivating GSNO and eliminating NOx
through NO expiration and/or reaction of NO with
heme iron(II) (Fig. 4). Of note, additional catabolic
enzymes have been proposed to exist in platelets [28],
airway epithelial cells [45], neutrophils [46], and Es-
cherichia coli [47]. However, none of these processes
have yet been shown to be physiologically relevant,
and many of the Km values for these enzymes are out
of the normal range for endogenous SNO substrate.
Inorganic reactions also cause SNO breakdown.
Intermediate Fe(S)NO formation involving LM thiol
groups may contribute to SNO catabolism [8]. Inor-
ganic reactions with copper are highly relevant to
S-nitrosocysteine breakdown in vitro [33]. These
may theoretically be less relevant in vivo, where
Fig. 3. Allosteric function of O2 in regulation of Hb S-nitrosylation. (a) Oxygenation accelerates S-nitrosylation of Hb. Rates of Hb
S-nitrosylation by S-nitrosocysteine (CYSNO) are faster in the oxy conformation (Hb(Feii]O2) than in the deoxy state (Hb(Feii]). B.
Deoxygenation accelerates denitrosylation of Hb. Rates of RSNO decomposition (and transfer) are much faster in the deoxy confor-
mation (SNO^Hb(Feii)] than in the oxy state [SNO^Hb(Feii)O2]. The decomposition of SNO^Hb(Feii) is further accelerated by the
presence of excess glutathione. Within the dead time of our measurements (V15 s), a major fraction of SNO^Hb(Feii) was converted
to GSNO (dashed line). Reproduced with permission from [16].
Table 1
Enzyme systems which break down GSNO in vitro
Enzyme Nitrogen oxide product
(Thioredoxin) thioredoxin reductase [22] Nitric oxide
Glutathione peroxidase [40] Nitric oxide
Q-Glutamyl transpeptidase [25,43] S-Nitroso-cysteinyl glycine
(Xanthine) Xanthine oxidase [39] Peroxynitrite
Glutathione-dependent formaldehyde dehydrogenase [42] Hydroxylaminea
aUnder conditions of excess reduced thiol.
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free copper(I) concentrations are low. However,
Cu(I) chelation results in inhibition of bioactivities
which are proposed to be related in GSNO catabo-
lism in platelets [28] and cardiac myocytes [48]. Of
note, the SNO catabolic e¡ects of other biological
transition metals are minimal compared with those
of Cu and Fe [49]. Finally, O32 has been shown to
cause CSNO and GSNO breakdown with second
order (in SNO) rate contents [50,51]. These reactions
are apparently ¢rst-order in O32 (overall kV3^
6U108 M32 s31). Therefore, WM SNO concentra-
tions would be degraded only very slowly (pM
min31 range) by these reactions in the presence of
nM O32 concentrations. However, in the presence
of activated neutrophils, SNO catabolism could be
signi¢cantly accelerated by those inorganic processes,
perhaps explaining low levels of SNOs observed in
the airways of patients with cystic ¢brosis [52].
7. Bioactivities resulting from S-nitros(yl)ation
reactions
7.1. Protein S-nitrosylation reactions
S-Nitrosothiol bioactivities arise partly from pro-
tein S-nitrosylation reactions, which may either alter
protein structure directly or lead to oxidation of vi-
cinal thiols [7,53]. An example of the former is the
structural activation of tissue plasminogen activator
[15,53], while an example of the latter is inactivation
of Yersinia enterocolitica phosphotyrosine protein
phosphatase [54]. These reactions a¡ect the function
of a broad spectrum of proteins ranging from
NMDA receptors in the central nervous system
[55,56] to the transcriptional regulatory proteins,
such as E. coli oxyR [47]. In this regard, the motif
cysteine^aspartate^glutamate has recently been pro-
posed to predict structural alterations based on cys-
teine nitrosylation, analogous to those for phosphor-
ylation. Acidic and basic amino acids are also
conserved in the N-terminal direction of nitrosyla-
tion-sensitive proteins, suggesting that S-nitrosyla-
tion signaling and bioactivity may be pH-sensitive
[55]. Of note, simple S-nitrosylation and cysteine ox-
idation may have di¡ering e¡ects on a given protein.
For example, progressive poly S-nitrosylation rever-
sibly activates the ryanodine-sensitive canine cardiac
Ca2 release channel, while oxidation of vicinal thi-
ols causes irreversible activation [57]. Of note, pro-
tein S-nitrosylation reactions may result from nitro-
sative stress associated with high environmental
Fig. 4. Proposed pathways of SNO metabolism in the airways and alveolus. After SNO formation in the airway and in erythrocytes
(RBC), transnitrosation reactions with glutathione (GSH) produce S-nitrosoglutathione (GSNO). GSNO undergoes catabolism to ni-
tric oxide (cNO) and lower mass SNOs, such as S-nitrosocysteinyl glycine (CGSNO) and S-nitrosocysteine (CSNO). These products
are either inactivated by leaving the lung (open arrows) or, like GSNO itself, exert bioactivity (dashed arrows) on smooth muscle
(S.M.), airway epithelium, in£ammatory cells and other targets.
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concentrations of NO donors, or from signaling
£uxes in physiological concentrations, perhaps ac-
counting for the paradoxical concentration-depen-
dent e¡ects on thymocyte apoptosis observed with
exposure to GSNO [58].
7.2. Extracellular SNOs: potential mechanisms of
action
It was once assumed that bioactivities of extracel-
lular SNOs depended upon their homolytic decom-
position to NO and the subsequent di¡usion of NO
into the cell. Though this mechanism is relevant
under certain circumstances, it has now also been
demonstrated that a variety of SNO bioactivities
(ranging from airway smooth muscle relaxation to
neuronal signaling) are unrelated to rate of release
of NO and, in fact, are inhibited by SNO breakdown
to NO [3,31,59^62]. Of particular interest in this re-
gard are the results of several investigators demon-
strating that S-nitroso-L-cysteine, but not the D-iso-
mer, has vascular smooth muscle and central nervous
system e¡ects in the rat, though both isomers decom-
pose to NO at the same rate [59,60]. Additionally,
large, stable SNOs with low membrane permeability
may have bioactivities comparable to those of small-
er, less stable molecules under certain circumstances
[31,62]. These observations suggest that there may be
membrane-based, stereoselective SNO bioactivities.
Mechanisms for this activity have been proposed to
include reactions with both membrane ion channels
and membrane signaling proteins. For example, there
is evidence that S-nitrosylation reactions may acti-
vate calcium-dependent vascular smooth muscle po-
tassium channels [63] and L-type cardiac calcium
channels [64]. Additionally, signaling through thiol
nitrosylation of a membrane G-protein (p21ras) has
been proposed [65]. However, activation of tradition-
al signaling cascades associated with regulated phos-
phorylation and/or dephosphorylation has not been
demonstrated, and there is no direct evidence for the
regulation of ion channels or p21ras through control
of SNO metabolism.
Because the catabolic products of certain extracel-
lular SNOs, which include NO, ONOO3, NH2OH
and S-nitrosocysteinyl glycine [22,25,39,40,42,43],
may have a broad range of distinct bioactivities, it
is tempting to speculate that SNO catabolic enzymes
may regulate the distribution of these species, and
thus regulate bioactivity, from the SNO reservoir.
For example, soluble guanylate cyclase activation in
the rat heart is inhibited by glutathione S-nitrosa-
tion, but upregulated in vitro by conditions favoring
GSNO catabolism to NO [48]. Indeed, accelerated
SNO catabolism to NO has been proposed to ac-
count, in part, for low SNO levels, airway smooth
muscle narrowing and high expired NO levels in sub-
jects with severe asthma [20].
7.3. Intracellular signaling
Many of intracellular signaling and metabolic pro-
teins are a¡ected by S-nitrosylation. These reactions
have e¡ects ranging from inhibition of post-transla-
tional protein tra⁄cking in the cell (as in the case of
translocation of the p47phox subunit of NADPH ox-
idase to the neutrophil cell membrane [66]) to tran-
scriptional regulation through IUB nitrosylation [67].
Additionally, metabolic processes may be regulated
by S-nitrosylation, including activation of the hexose
Table 2
S-Nitrosothiols inhibit enzymes in glutathione metabolic pathways
Enzyme Inhibition by (S)NO: mechanism IC50/Ki
Q-Glutamyl-cysteine-synthetase [72] Decreased (rat hepatocyte) enzyme activity through thiol nitrosylation NAb
Glutathione-S-transferase [70] Competitive inhibitiona V0.015 mM
Glutathione reductase [69] Competitivea ; active Cys-63 nitrosylationa ; SCN rearrangement
(irreversible inhibition)
0.5 or (Ki) 1 mM
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monophosphate shunt [29], though these pathways
are not clearly de¢ned. It is also of interest that
GSNO and other SNOs may inhibit enzymes associ-
ated with response to oxidative stress in eukaryotic
cells (Table 2), including glutathione peroxidase
[68,71], glutathione reductase [69], glutathione-S-
transferase [70], and Q-glutamyl cysteine synthase
[72]. Concentrations required for these activities
are, in some cases, in the physiological range, argu-
ing for relevance to routine signaling rather than
simply to the nitrosative stress response. Both regu-
latory and stress-related S^NO-mediated reactions
have been demonstrated in prokaryotic cells which
are analogous to those described for eukaryotic cells.
For example, SNOs upregulate the oxidative stress
response transcription factor oxyR in E. coli [47].
In this regard, it is important to recognize that sen-
sitive intracellular signaling mechanisms in prokary-
otic and eukaryotic cells may be overwhelmed by
high SNO concentrations under circumstances of in-
£ammation and other types of exogenous nitrosative
stress [6,15].
7.4. Antimicrobial cytotoxicity
It has been known for over a decade that SNOs
have antimicrobial properties [73]. Indeed, Salmonel-
la species have developed a speci¢c metabolic path-
way involving upregulation of homocysteine produc-
tion to protect against SNO-mediated cytotoxicity,
and expression of the responsible met L gene product
is actually a previously unrecognized virulence factor
[74]. Additionally, thiol nitrosylation of metabolic
enzymes in Trypanosoma cruzi may be responsible
for the inhibitory e¡ect of ONOO3 on this species
[75]. Furthermore, S-nitrosylation of E. coli ribonu-
cleotide reductase, the rate-limiting enzyme in DNA
synthesis, inhibits bacterial replication [76]. High
GSNO concentrations in the airway lining £uid [6]
in neutrophils [29] may therefore serve, under certain
conditions, an antimicrobial role.
8. Summary
Sulfhydryl^NO interactions may serve both to sta-
bilize and to activate NO. In many biological sys-
tems, there are SNO reservoirs which may be distrib-
uted to di¡erent bioactivities, ranging from cell
signaling to cytotoxicity ^ by mechanisms ^ such as
catabolic regulation. S-Nitrosylation reactions acti-
vate and inhibit proteins through conformational
changes analogous to those occurring with protein
phosphorylation. Some of these reactions are inde-
pendent of homolytic cleavage of the S^NO bond,
and, in fact, appear under certain circumstances to
involve stereoselective recognition by the protein of
the intact SNO species. In vivo, NO without thiol
groups may be unprotected and ine¡ectively deliv-
ered to the site of action. These observations add a
layer of complexity to our understanding of NO bi-
ology, and o¡er promising targets for the develop-
ment of new therapies.
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